Extracellular matrix is a source of mitogenically active platelet-derived growth factor

Journal of Cellular Physiology

Volumn 168, Issue 2, 1996, Pages 322-332

  Field, Susan L ^a   Khachigian, Levon M ^a   Sleigh, Merilyn J ^b,c   Yang, Guchen ^a,d   Vandermark, Sarah E ^b,e   Hogg, Philip J ^a   Chesterman, Colin N ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b CSIRO   (Australia)

^c Peptide Technology Ltd   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

^e Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; APROTININ; CAPTOPRIL; CELL RECEPTOR; HEPARIN; HIRUDIN; PLASMIN; PLASMINOGEN ACTIVATOR; PLATELET DERIVED GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; CHO CELL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; HAMSTER; HUMAN; HUMAN CELL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ANTIBODIES; BLOTTING, WESTERN; CELL DIVISION; CELLS, CULTURED; CHO CELLS; CRICETINAE; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; MICE; MITOGENS; MUTATION; PLASMIN; PLASMINOGEN ACTIVATORS; PLATELET-DERIVED GROWTH FACTOR; RABBITS; SERINE PROTEINASE INHIBITORS; TRANSFECTION;

EID: 0029757490     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199608)168:2<322::AID-JCP11>3.0.CO;2-5     Document Type: Article

References (45)

1. Barrett, T.B., Gajdusek, C.M., Schwartz, S.M., McDougall, J.K., and Benditt, E.P. (1984) Expression of the sis gene by endothelial cells in culture and in vivo. Proc. Natl. Acad. Sci. U.S.A., 81:6772-6774.
2. Blasi, F. (1988) Surface receptors for urokinase plasminogen activator. Fibrinolysis, 2:73-84.
3. Bornstein, P., and Sage, E.H. (1994) Thrombospondins. In: Methods in Enzymology. Academic Press, Inc., New York, Vol. 245, pp. 62-84.
4. Brunner, G., Gabrilove, J., Rifkin, D.B., and Wilson, E.L. (1991) Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan. J. Cell Biol., 114:1275-1283.
5. Clezardin, P., Malaval, L., Ehrensperger, A.-S., Delmas, P.D., Dechavanne, M., and McGregor, J.L. (1988) Complex formation of human thrombospondin with osteonectin. Eur. J. Biochem., 175:275-284.
6. Collins, T., Bonthron, D.T., and Orkin, S.H. (1987a) Alternative RNA splicing affects function of encoded platelet-derived growth factor A chain. Nature, 328:621-624.
7. Collins, T., Pober, J.S., Gimbrone, M.A., Jr., Hammacher, A., Betsholtz, C., Westermark, B., and Heldin, C.-H. (1987b) Cultured human endothelial cells express platelet-derived growth factor A chain. Am. J. Pathol., 126:7-12.
8. Fager, G., Camejo, G., Olsson, U., Ostergren-Lunden, G., Lustig, F., and Bondjers, G. (1995) Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells. J. Cell. Physiol., 163:380-392.
9. Fen, Z., and Daniel, T.O. (1991) 5′ untranslated sequences determine degradative pathway for alternate PDGF B/c-sis mRNA's. Oncogene, 6:953-959.
10. Ferns, G.A.A., Reidy, M.A., and Ross, R. (1991) Ballon catheter deendothelialization of the nude rat carotid. Response to injury in the absence of functional T lymphocytes. Am. J. Pathol., 138:1045-1057.
11. Flaumenhaft, R., and Rifkin, D.B. (1992) The extracellular regulation of growth factor action. Mol. Biol. Cell, 3:1057-1065.
12. Harlan, J.M., Thompson, P.J., Ross, R.R., and Bowen-Pope, D.F. (1986) α-thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells. J. Cell Biol., 103:1129-1133.
13. Hebert, C.A., and Baker, J.B. (1988) Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: Colocalization of cell surface urokinase with vinculin. J. Cell Biol., 106:1241-1247.
14. Heldin, C.-H. (1992) Structural and functional studies on platelet-derived growth factor. EMBO J., 11:4251-4259.
15. Heldin, C.-H., Backstrom, G., Ostman, A., Hammacher, A., Ronnstrand, L., Rubin, K., Nister, M., and Westermark, B. (1988) Binding of different dimeric forms of PDGF to human fibroblasts: Evidence for two separate receptor types. EMBO J., 7:1387-1393.
16. Hogg, P.J., Stenflo, J., and Mosher, D.F. (1992) Thrombospondin is a slow tight-binding inhibitor of plasmin. Biochemistry, 31:265-269.
17. Hogg, P.J., Stathakis, P., Jimenez, B.M., and Chesterman, C.N. (submitted) Platelet-derived growth factor binds specifically and tightly to thrombospondin 1.
18. Jaffe, E.A., Nachman, R.L., Becker, C.G., and Minick, C.R. (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest., 52:2745-2756.
19. Kazlauskas, A., Bowen-Pope, D., Seifert, R., Hart, C.E., and Cooper, J.A. (1988) Different effects of homo- and heterodimers of platelet-derived growth factor A and B chains on human and mouse fibroblasts. EMBO J., 7:3727-3735.
20. Kelly, J.L., Sanchez, A., Brown, G.S., Chesterman, C.N., and Sleigh, M.J. (1993) Accumulation of PDGF B and cell-binding forms of PDGF A in the extracellular matrix. J. Cell Biol., 121:1153-1163.
21. Khachigian, L.M., and Chesterman, C.N. (1994) Structural basis for the extracellular retention of PDGF A-chain using a synthetic peptide corresponding to exon 6. Peptides, 15:133-137.
22. Klagsbrun, M. (1992) Mediators of angiogenesis: The biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Semin. Cancer Biol., 3:81-87.
23. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227:680-685.
24. Lane, T.F., and Sage, E.H. (1994) The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J., 8:163-173.
25. LaRochelle, W.J., May-Siroff, M., Robbins, K.C., and Aaronson, S.A. (1991) A novel mechanism regulating growth factor association with the cell surface: Identification of a PDGF retention domain. Genes Dev., 5:1191-1199.
26. Majack, R.A., Goodman, L.V., and Dixit, V.M. (1988) Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J. Cell Biol., 106:415-422.
27. Meissauer, A., Kramer, M.D., Schirrmacher, V., and Brunner, G. (1992) Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: A key event in melanoma cell invasiveness in vitro. Exp. Cell Res., 199:179-190.
28. Olashaw, N.E., Kusmik, W., Daniel, T.O., and Pledger, W.J. (1991) Biochemical and functional discrimination of platelet-derived growth factor α and β receptors in BALB/C-3T3 cells. J. Biol. Chem., 266:10234-10240.
29. Ostman, A., Backstrom, G., Fong, N., Betsholtz, C., Wernstedt, C., Hellman, U., Westermark, B., Valenzuela, P., and Heldin, C.-H. (1989) Expression of three recombinant homodimeric isoforms of PDGF in Saccharomyces cerevisiae: evidence for difference in receptor binding and functional activities. Growth Factors, 1:271-281.
30. Ostman, A., Andersson, M., Betsholtz, C., Westermark, B., and Heldin, C.-H. (1991) Identification of a cell retention signal in the B-chain of platelet-derived growth factor and in the long splice version of the A-chain. Cell Regul., 2:503-512.
31. Pekny, M., Ostman, A., Hermansson, A., Nister, M., Heldin, C.-H., and Westermark, B. (1994) Differences in binding to the solid substratum and extracellular matrix may explain isoform-specific paracrine effects of platelet-derived growth factor. Growth Factors, 10:77-87.
32. Pfeilschifter, J., Krempien, R., Naumann, A., Gronwald, R.G.K., Hoppe, J., and Ziegler, R. (1992) Differential effects of platelet-derived growth factor isoforms on plasminogen activator activity in fetal rat osteoblasts due to isoform-specific receptor functions. Endocrinology, 130:2059-2066.
33. Pollock, R.A., and Richardson, W.D. (1992) The alternative-splice isoforms of the PDGF A-chain differ in their ability to associate with the extracellular matrix and to bind heparin in vitro. Growth Factors, 7:267-277.
34. Raines, E.W., and Ross, R. (1992) Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences. J. Cell Biol., 116:533-543.
35. Raines, E.W., Lane, T.F., Iruela-Arispe, M.L., Ross, R., and Sage, E.H. (1992) The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc. Natl. Acad. Sci. U.S.A., 89:1281-1285.
36. Ross, R. (1993) The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature, 362:801-809.
37. Rylatt, D.B., Blake, A.S., Cottis, L.E., Massingham, D.A., Fletcher, W.A., Masci, P.P., Whitaker, A.N., Elms, M., Bunce, I., Webber, A.J., Wyatt, D., and Bundesen, P.G. (1983) An immunoassay for human D dimer using monoclonal antibodies. Thromb. Res., 31:767-778.
38. Saksela, O., and Rifkin, D.B. (1990) Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell Biol., 110:767-775.
39. Sane, D.C., Moser, T.L., and Greenberg, C.S. (1991) Limited proteolysis of vitronectin by plasmin destroys heparin binding activity. Thromb. Haemost., 66:310-314.
40. Sato, Y., and Rifkin, D.B. (1989) Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture. J. Cell Biol., 109:309-315.
41. Soyombo, A.A., and DiCorleto, P.E. (1994) Stable expression of human platelet-derived growth factor B chain by bovine aortic endothelial cells. Matrix association and selective proteolytic cleavage by thrombin. J. Biol. Chem., 269:17734-17740.
42. Sperti, G., van Leeuwen, R., Maseri, A., and Kluft, C. (1992) Platelet-derived growth factor increases plasminogen activator inhibitor-1 activity and mRNA in rat cultured vascular smooth muscle. Ann. N.Y. Acad. Sci., 667:178-180.
43. Vlodavsky, I., Korner, G., Ishai-Michaeli, R., Bashkin, P., Bar-Shavit, R., and Fuks, Z. (1990) Extracellular matrix-resident growth factors and enzymes: Possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev., 9:203-226.
44. Yabkowitz, R., Mansfield, P.J., Ryan, U.S., and Suchard, S.J. (1993) Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary artery smooth muscle cells. J. Cell. Physiol., 157:24-32.
45. Yamaguchi, Y., Mann, D.M., and Ruoslahti, E. (1990) Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature, 346:281-284.